Baylor University Medical Center, part of Baylor Scott & White Health, is a not-for-profit hospital in Dallas, Texas. It has 1,025 licensed beds and is one of the major centers for patient care, medical training and research in North Texas.

There are 1,025 beds in Baylor Scott and White Health.

During the past decade, Baylor Scott and White Health conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 4 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor Scott and White Health" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Radiation Therapy Oncology Group" with 2 trials sponsored, "University of California, San Francisco" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Amryt Pharma" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor Scott and White Health" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "AbCellera Biologics Inc." with 2 trials as a collaborator, "Baylor Scott and White Health" with 2 trials as a collaborator, "Duke University" with 2 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 2 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Baylor Scott and White Health" are "COVID-19" (2 trials), "Adverse Effects" (1 trials), "Alcohol-Related Disorders" (1 trials), "Alcoholic Hepatitis" (1 trials) and "Anemia" (1 trials). Many other conditions were trialed in "Baylor Scott and White Health" in a lesser frequency.

Most popular intervention types in "Baylor Scott and White Health" are "Drug" (13 trials), "Radiation" (3 trials), "Behavioral" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "radiation therapy" (3 trials), "Bamlanivimab" (1 trials), "Basic medication therapy management" (1 trials) and "Bebtelovimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor Scott and White Health" are 20 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Baylor Scott and White Health". undefined are not yet recruiting, 8 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 11 completed trials in Baylor Scott and White Health, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Scott and White Health, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".